Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - CASH FROM OPERATIONS
Cash from Operations CHRS - Coherus BioSciences, Inc.
-175 M
LAST VALUE
-116.15%
2 YEAR CAGR
-1.89%
5 YEAR CAGR
-28.57%
10 YEAR CAGR